A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
This is the first study of oral tofacitinib in adults with active ankylosing spondylitis. It is designed to obtain information on the efficacy and safety of 3 different doses of tofacitinib.
Inclusion Criteria:
Exclusion Criteria:
Ballantyne, North Carolina 28277, United States
Seatle, Washington 98122, United States
Praha 11- Chodov, 14800, Czechia
Vogelsang-Gommern, 39245, Germany
Bialystok, 15- 879, Poland
Elblag, 82-300, Poland
Torun, 87-100, Poland
Yekaterinburg, 620149, Russia